by In2Pharma | Aug 20, 2026 | News
Belgium The Federal Agency for Medicines and Health Products (FAMHP, Belgium) has published an updated version of its guidelines for Additional Risk Minimisation Activities (version 08/2026). The updated guidelines are available in Dutch and French and all changes...
by In2Pharma | Feb 12, 2018 | News
FAMHP The guidelines on labeling of medicines have been adapted. With these adaptations, the guidelines are more in line with the European and other national and international guidelines. Main changes are: Information in braille: the strength and/or pharmaceutical...
by In2Pharma | Sep 12, 2017 | News
FAMHP Recently, FAMHP published guidelines as well as Q&A documents related to the Falsified Medicines Directive. No later than 9 February 2019, safety features as imposed by the Falsified Medicines Directive 2011/62/EU of the European Parliament and of the...
by In2Pharma | May 10, 2017 | News
EMA The Committee for Medicinal Products for Veterinary Use (CVMP) has updated the current guidelines on veterinary medicines for minor uses and minor species (MUMS). These revised guidelines provide more clarity on data requirements and include three guidelines...
